Companies: 10,795·Total market cap: $144.5T
Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc.

ALLRNASDAQHealthcare● Active
$1.58
$-0.03(-1.86%)
Market Cap$25138944
P/E Ratio
52W High$2.35
52W Low$0.769

Allarity Therapeutics, Inc. (ALLR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ALLR · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Allarity Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

ALLR insider buying and selling by quarter

ALLR insider selling · ALLR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
646K323K0
2023 Q3
2024 Q3
2025 Q1
2025 Q3

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · ALLR ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ALLR executive sell shares · ALLR board member insider trading · ALLR insider trading SEC filing

Showing 11 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Jensen Thomas

CEO

Award

Date

Jan 28

Shares

200,000

Price

Value

View Form 4 on SEC.gov

Hoeiland Jesper

Director

Award

Date

Jan 7

Shares

25,000

Price

Value

View Form 4 on SEC.gov

McLaughlin Gerald W.

Director

Award

Date

Jan 28

Shares

45,000

Price

Value

View Form 4 on SEC.gov

Ervin Jeffrey S

CFO

Award

Date

Jan 28

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Graff Jeremy R.

See Remarks

Award

Date

Jan 7

Shares

133,333

Price

Value

View Form 4 on SEC.gov

Graff Jeremy R.

See Remarks

Option

Date

Sep 30

Shares

39,494

Price

Value

View Form 4 on SEC.gov

Graff Jeremy R.

See Remarks

Other

Date

Sep 30

Shares

14,613

Price

$1.58

Value

$23K

View Form 4 on SEC.gov

Graff Jeremy R.

CDO

Award

Date

Jan 22

Shares

144,441

Price

Value

View Form 4 on SEC.gov

Epshinsky Alexander

CFO

Award

Date

Jan 22

Shares

29,496

Price

Value

View Form 4 on SEC.gov

Jensen Thomas

CEO

Award

Date

Jan 22

Shares

396,734

Price

Value

View Form 4 on SEC.gov

Graff Jeremy R.

See Remarks

Award

Date

Sep 30

Shares

118,483

Price

$2.11

Value

$250K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ALLR insider trading

ALLR insider trades

Allarity Therapeutics, Inc. (ALLR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Graff Jeremy R. (See Remarks), Jensen Thomas (CEO), Hoeiland Jesper (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ALLR insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Allarity Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

ALLR insider trading · 5 questions

The insiders of Allarity Therapeutics, Inc. (ALLR) include executives and directors such as Graff Jeremy R. (See Remarks), Jensen Thomas (CEO), Hoeiland Jesper (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ALLR board member insider tradingwho are ALLR insidersALLR insider rosterAllarity Therapeutics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026